PubRank

Walter Keller

Author PubWeight™ 96.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A new yeast poly(A) polymerase complex involved in RNA quality control. PLoS Biol 2005 5.43
2 RNA-specific ribonucleotidyl transferases. RNA 2007 2.15
3 Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length. Cell Rep 2012 2.07
4 A role for SSU72 in balancing RNA polymerase II transcription elongation and termination. Mol Cell 2002 2.06
5 WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol 2005 1.97
6 Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. EMBO J 2004 1.92
7 Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3' end processing and splicing. Mol Cell 2006 1.86
8 An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. EMBO J 2006 1.79
9 Distinct sequence motifs within the 68-kDa subunit of cleavage factor Im mediate RNA binding, protein-protein interactions, and subcellular localization. J Biol Chem 2004 1.78
10 The structure and binding behavior of the bacterial cell surface layer protein SbsC. Structure 2008 1.72
11 Independent functions of yeast Pcf11p in pre-mRNA 3' end processing and in transcription termination. EMBO J 2003 1.72
12 Yhh1p/Cft1p directly links poly(A) site recognition and RNA polymerase II transcription termination. EMBO J 2002 1.71
13 RNA editing by adenosine deaminases generates RNA and protein diversity. Biochimie 2002 1.64
14 Functional analysis of yeast snoRNA and snRNA 3'-end formation mediated by uncoupling of cleavage and polyadenylation. Mol Cell Biol 2002 1.49
15 Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE. Immunol Cell Biol 2012 1.41
16 tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli. EMBO J 2002 1.38
17 Distinct roles of non-canonical poly(A) polymerases in RNA metabolism. PLoS Genet 2009 1.33
18 Structural basis for nucleic acid and toxin recognition of the bacterial antitoxin CcdA. J Mol Biol 2006 1.32
19 Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals. EMBO J 2007 1.27
20 Biochemical and structural insights into substrate binding and catalytic mechanism of mammalian poly(A) polymerase. J Mol Biol 2004 1.26
21 Dimerization of the major birch pollen allergen Bet v 1 is important for its in vivo IgE-cross-linking potential in mice. J Immunol 2005 1.22
22 Functions for S. cerevisiae Swd2p in 3' end formation of specific mRNAs and snoRNAs and global histone 3 lysine 4 methylation. RNA 2004 1.22
23 The role of the yeast cleavage and polyadenylation factor subunit Ydh1p/Cft2p in pre-mRNA 3'-end formation. Nucleic Acids Res 2003 1.15
24 The solution structure of ParD, the antidote of the ParDE toxin antitoxin module, provides the structural basis for DNA and toxin binding. Protein Sci 2007 1.14
25 Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol 2013 1.14
26 Sequence motifs that distinguish ATP(CTP):tRNA nucleotidyl transferases from eubacterial poly(A) polymerases. RNA 2004 1.14
27 The anti-toxin ParD of plasmid RK2 consists of two structurally distinct moieties and belongs to the ribbon-helix-helix family of DNA-binding proteins. Biochem J 2002 1.06
28 Gene regulation: reviving the message. Nature 2002 1.05
29 Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem 2003 1.04
30 Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy. J Immunol 2002 1.03
31 A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype. J Immunol 2013 1.02
32 Cleavage factor Im is a key regulator of 3' UTR length. RNA Biol 2012 1.00
33 Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering. Mol Immunol 2008 0.99
34 PAPD5, a noncanonical poly(A) polymerase with an unusual RNA-binding motif. RNA 2011 0.99
35 Crystal structure of the 25 kDa subunit of human cleavage factor Im. Nucleic Acids Res 2008 0.99
36 A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination. J Allergy Clin Immunol 2005 0.99
37 TraA and its N-terminal relaxase domain of the Gram-positive plasmid pIP501 show specific oriT binding and behave as dimers in solution. Biochem J 2005 0.98
38 Prediction of IgE-binding epitopes by means of allergen surface comparison and correlation to cross-reactivity. J Allergy Clin Immunol 2011 0.97
39 Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy. Int Arch Allergy Immunol 2008 0.95
40 Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense. J Nat Prod 2011 0.95
41 The 2.5 Å structure of the enterococcus conjugation protein TraM resembles VirB8 type IV secretion proteins. J Biol Chem 2012 0.94
42 Conjugative type IV secretion systems in Gram-positive bacteria. Plasmid 2013 0.92
43 The TraA relaxase autoregulates the putative type IV secretion-like system encoded by the broad-host-range Streptococcus agalactiae plasmid pIP501. Microbiology 2006 0.92
44 Means to an end: mechanisms of alternative polyadenylation of messenger RNA precursors. Wiley Interdiscip Rev RNA 2013 0.91
45 TraG encoded by the pIP501 type IV secretion system is a two-domain peptidoglycan-degrading enzyme essential for conjugative transfer. J Bacteriol 2013 0.91
46 Mimotopes identify conformational B-cell epitopes on the two major house dust mite allergens Der p 1 and Der p 2. Mol Immunol 2007 0.91
47 A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy. J Immunol 2007 0.91
48 Determinants of substrate specificity in RNA-dependent nucleotidyl transferases. Biochim Biophys Acta 2007 0.91
49 Cooking birch pollen-related food: divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo. J Allergy Clin Immunol 2006 0.90
50 Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly. J Allergy Clin Immunol 2010 0.89
51 The structure of bacterial S-layer proteins. Prog Mol Biol Transl Sci 2011 0.89
52 Cloning, expression, and mapping of allergenic determinants of alphaS1-casein, a major cow's milk allergen. J Immunol 2009 0.89
53 Ground vegetation monitoring in Swiss forests: comparison of survey methods and implications for trend assessments. Environ Monit Assess 2010 0.88
54 Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity. J Immunol 2007 0.88
55 Arginine methylation in subunits of mammalian pre-mRNA cleavage factor I. RNA 2010 0.87
56 The cross-reactive calcium-binding pollen allergen, Phl p 7, reveals a novel dimer assembly. EMBO J 2002 0.87
57 The role of the putative 3' end processing endonuclease Ysh1p in mRNA and snoRNA synthesis. RNA 2008 0.87
58 S-adenosyl-L-homocysteine hydrolase and methylation disorders: yeast as a model system. Biochim Biophys Acta 2012 0.87
59 Crystallization and preliminary structure determination of the C-terminal truncated domain of the S-layer protein SbsC. Acta Crystallogr D Biol Crystallogr 2003 0.86
60 Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7. J Immunol 2004 0.86
61 Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies. Protein Expr Purif 2006 0.85
62 Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity. FASEB J 2002 0.85
63 Crystallization and preliminary structure determination of the plant food allergen Pru av 2. Acta Crystallogr Sect F Struct Biol Cryst Commun 2005 0.85
64 Three-dimensional structure of the cross-reactive pollen allergen Che a 3: visualizing cross-reactivity on the molecular surfaces of weed, grass, and tree pollen allergens. J Immunol 2008 0.84
65 Biochemical characterization of three putative ATPases from a new type IV secretion system of Aeromonas veronii plasmid pAC3249A. BMC Biochem 2010 0.84
66 Characterization of a novel isoform of alpha-nascent polypeptide-associated complex as IgE-defined autoantigen. J Invest Dermatol 2002 0.84
67 Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer. Mol Immunol 2010 0.83
68 Biophysical characterization of recombinant HIV-1 subtype C virus infectivity factor. Amino Acids 2010 0.82
69 Molecular characterization of recombinant T1, a non-allergenic periwinkle (Catharanthus roseus) protein, with sequence similarity to the Bet v 1 plant allergen family. Biochem J 2003 0.82
70 Crystal structure and immunologic characterization of the major grass pollen allergen Phl p 4. J Allergy Clin Immunol 2013 0.81
71 Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy. Eur J Immunol 2002 0.81
72 Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J 2011 0.81
73 The high-molecular-mass amylase (HMMA) of Geobacillus stearothermophilus ATCC 12980 interacts with the cell wall components by virtue of three specific binding regions. Mol Microbiol 2009 0.81
74 Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein. J Immunol 2008 0.80
75 Circular dichroism analysis of allergens. Methods 2004 0.80
76 Towards the structure of the C-terminal part of the S-layer protein SbsC. Acta Crystallogr Sect F Struct Biol Cryst Commun 2009 0.78
77 Hypoallergenic mutants of the Timothy grass pollen allergen Phl p 5 generated by proline mutations. Int Arch Allergy Immunol 2012 0.78
78 A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin. J Immunol 2007 0.78
79 Conjugation in Gram-Positive Bacteria. Microbiol Spectr 2014 0.78
80 Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation. Transpl Int 2004 0.78
81 Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles. J Immunol 2004 0.78
82 Visualization of clustered IgE epitopes on alpha-lactalbumin. J Allergy Clin Immunol 2010 0.78
83 X-filtering for a range of coupling constants: application to the detection of intermolecular NOEs. J Magn Reson 2003 0.77
84 Crystallization and preliminary structure determination of the transfer protein TraM from the Gram-positive conjugative plasmid pIP501. Acta Crystallogr Sect F Struct Biol Cryst Commun 2013 0.76
85 Backbone resonance assignment of Alt a 1, a unique β-barrel protein and the major allergen of Alternaria alternata. Biomol NMR Assign 2013 0.76
86 Crystallization of domains involved in self-assembly of the S-layer protein SbsC. Acta Crystallogr Sect F Struct Biol Cryst Commun 2012 0.75
87 Crystallization and first data collection of the putative transfer protein TraN from the Gram-positive conjugative plasmid pIP501. Acta Crystallogr Sect F Struct Biol Cryst Commun 2012 0.75
88 Three-dimensional structure of the panallergen Phl p 7. Int Arch Allergy Immunol 2003 0.75
89 Bacterially expressed and optimized recombinant Phl p 1 is immunobiochemically equivalent to natural Phl p 1. Biochim Biophys Acta 2006 0.75
90 Effect of protamine on the solubility and deamidation of human growth hormone. Int J Pharm 2012 0.75